Global X Genomics & Biotechnology ETF
GNOM
61 hedge funds and large institutions have $36.4M invested in Global X Genomics & Biotechnology ETF in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 11 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
3% less funds holding
Funds holding: 63 → 61 (-2)
8.27% less ownership
Funds ownership: 17.53% → 9.26% (-8.3%)
71% less capital invested
Capital invested by funds: $124M → $36.4M (-$87.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$5.56M |
| 2 |
CA
Corrado Advisors
Ramsey,
New Jersey
|
+$563K |
| 3 |
PWM
Prosperity Wealth Management
San Ramon,
California
|
+$480K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$305K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$212K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$90.3M |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$5.67M |
| 3 |
MWAM
Manhattan West Asset Management
Los Angeles,
California
|
-$850K |
| 4 |
EWM
Elmwood Wealth Management
Berkeley,
California
|
-$677K |
| 5 |
Lido Advisors
Los Angeles,
California
|
-$565K |
GNOM Hedge Fund Activity: Q4 2023 in Review
61 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q4 2023, worth a combined $36.4M — down 71% from $124M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of GNOM and 10 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 17 added.
The largest buyer was Jane Street, adding an estimated $5.56M. The largest seller was Northwestern Mutual Wealth Management, cutting an estimated $90.3M.
- 61 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q4 2023, down from 63 in Q3 2023.
- Funds reported $36.4M of Global X Genomics & Biotechnology ETF stock for Q4 2023, down 71% quarter-over-quarter.
- 10 funds opened new Global X Genomics & Biotechnology ETF positions in Q4 2023 and 11 closed out, a net change of -1 holder.
- The largest Global X Genomics & Biotechnology ETF buyer in Q4 2023 was Jane Street, an estimated $5.56M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q4 2023 was Northwestern Mutual Wealth Management, an estimated $90.3M sold.
Based on aggregated 13F filings for Q4 2023.